Found 1281 matching trials
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
PHASE2The goal of this prospective study is to explore the safety and preliminary...
Location
Fudan University Shanghai Cancer Center
Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer
PHASE2This phase II trial studies the effect of bintrafusp alfa with pemetrexed a...
Location
M D Anderson Cancer Center
Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma
PHASE1This phase I trial studies the side effects and best dose of selinexor when...
Location
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
PHASE2RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
AZD9291 First Time In Patients Ascending Dose Study
PHASE1This study will treat patients with advanced NSCLC who have already receive...
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
PHASE2This clinical trial is evaluating tucatinib in combination with Doxil in pa...
Location
Maryland Oncology Hematology
A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors
PHASE1This is an open-label, two-arm, Phase I, dose escalation study to evaluate ...
Location
GSK Investigational Site
A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma
PHASE2There is no standard treatment for chondrosarcoma. Some small sample of stu...
Location
The Second Affiliated Hospital of Zhejiang University School of Medicine
Treatment of CD79B Mutant Relapsed/Refractory Diffuse Large B-Cell Lymphoma With Bruton Tyrosine Kinase Inhibitor Zanubrutinib
PHASE2The goal of this clinical trial was to evaluate whether zanubrutinib can ef...
Location
Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital
Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2
PHASE1This is a phase I study of second primary tumor prevention in early stage (...
Location
Emory University Winship Cancer Institute